Clinical Trials · NCT06721507
2024 Tirzepatide-Bariatric Surgery
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Marlene Starr
- Enrollment
- 50
- Start date
- Mar 2025
- Locations
- 1 site, United States
- Primary endpoint
- Change in inflammatory markers c reactive protein (CRP)